# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001401914-22-000043
Filing Date
2022-04-29
Accepted
2022-04-29 16:06:53
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | defa14a2022additionalproxy.htm | DEFA14A | 11862
2 |  | darena2022_pagex1a.jpg | GRAPHIC | 510315
3 |  | darena2022_pagex2a.jpg | GRAPHIC | 427463
| Complete submission text file | 0001401914-22-000043.txt |  | 1304126

Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36395 | Film No.: 22875239
SIC: 2834 Pharmaceutical Preparations